Navigation Links
K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission
Date:12/27/2010

have an adverse effect on us if we are not able to refinance it or repay it at maturity on March 20, 2013, or earlier if we experience an event of default and such terms contain numerous affirmative and negative covenants and conditions that must be met in order to avoid default and/or to qualify for additional loan tranches, and there are substantial risks of triggering defaults with respect to such covenants and/or the occurrence or non-occurrence of conditions that would preclude the Company from being able to draw down additional loan tranches, which could materially adversely impact the Company, lead to foreclosure on the Company assets acting as collateral for the loan agreement, and adversely affect the Company's ability to operate;

(3)  the possibility of not obtaining FDA approvals or delay in obtaining FDA approvals, including with respect to the drug originally submitted under the trade name Gestiva™ ("Gestiva™")

(4)  new product development and launch, including the possibility that any product launch may be delayed or unsuccessful, including with respect to Gestiva™;

(5)  acceptance of and demand for the Company's new pharmaceutical products, including Gestiva™, and for our current products upon their return to the marketplace, as well as the number of preterm births for which Gestiva™ may be prescribed and its safety profile and side effects profile;

(6)  the possibility that any period of exclusivity may not be realized, including with respect to Gestiva™, a designated Orphan Drug;

(7)  the satisfaction or waiver of the terms and conditions for the acquisition of the full U.S. and worldwide rights to Gestiva™ set forth in the previously disclosed Gestiva™ acquisition agreement, as amended;

(8)  the consent decree between the Company and the U.S. Food and Drug Administration ("FDA") and the Company's suspension of the production and
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 5, 2015  IQPC,s 19 th ... announce the chairman of the Summit Mr. Phani Bidarahalli ... will be joined by the expert speaker faculty including senior ... May 11 – 12, at The Hotel Kabuki in ... is available for download on the event website, which can ...
(Date:5/5/2015)...  Accuray Incorporated (Nasdaq: ARAY ), announced today that ... America Merrill Lynch 2015 Healthcare Conference in ... at 2:20pm PT.   A live webcast ... Relations page of the Company,s website at http://www.accuray.com/investors ... approximately one hour after the conclusion of the live ...
(Date:5/5/2015)... , May 5, 2015  Image Stream Medical, ... new agreement with MedAssets, one of the largest group ... the United States.  Under terms of the three-year agreement, ... and services will be made available to MedAssets members ... the partnership, Image Stream Medical CEO Eddie Mitchell ...
Breaking Medicine Technology:Phani Bidarahalli from Wipro to chair the upcoming 19th Software Design for Medical Devices Summit in San Francisco 2Image Stream Medical Announces Agreement with MedAssets 2
... (NYSE: PFE ) announced today it is ... myeloid leukemia (CML) based on data from a clinical ... treated patients.  These regulatory submissions are planned for 2011. ... has begun the process of preparing a Marketing Authorization ...
... 3, 2010 US Oncology, Inc ., the nation,s ... with US Oncology Research participated in studies that ... Hematology ( ASH ) Annual Meeting and Exposition at the ... other investigators in the US Oncology Research Network participated in ...
Cached Medicine Technology:Pfizer Plans Regulatory Submissions of Bosutinib in Chronic Myeloid Leukemia 2Pfizer Plans Regulatory Submissions of Bosutinib in Chronic Myeloid Leukemia 3Pfizer Plans Regulatory Submissions of Bosutinib in Chronic Myeloid Leukemia 4Pfizer Plans Regulatory Submissions of Bosutinib in Chronic Myeloid Leukemia 5US Oncology Research Investigators Participated in Studies That Will be Presented at the 2010 American Society of Hematology Annual Meeting and Exposition 2US Oncology Research Investigators Participated in Studies That Will be Presented at the 2010 American Society of Hematology Annual Meeting and Exposition 3US Oncology Research Investigators Participated in Studies That Will be Presented at the 2010 American Society of Hematology Annual Meeting and Exposition 4
(Date:5/5/2015)... The brains of people with type 1 ... slower information processing, according to research led by the ... . , The findings indicate that clinicians should ... cognitive difficulties. If progressive, these changes could influence their ... the National Institutes of Health (NIH), is ...
(Date:5/5/2015)... California (PRWEB) May 05, 2015 On ... Downtown Los Angeles, CA, Choices Recovery sponsored Durkin Entertainment’s ... Durkin, LA’s leading producer of sustainable product placement in ... of the world’s top providers of ecologically sound and ... a premier red carpet event that makes appearances at ...
(Date:5/5/2015)... What do you get when you combine ... greatest mountaineers and one of the world’s greatest causes? The ... documentary by Marc Middleton, which follows world-renowned mountaineer Chris Warner ... 19,341-foot frozen summit of Mount Kilimanjaro. , “This film ... to action. Viewers are moved to ask, ‘What can I ...
(Date:5/5/2015)... 05, 2015 Buckeye Health Plan (BHP) ... CEO and plan president of Buckeye Health Plan. Hill, ... position immediately. , Hill has more than 28 years ... Pacific Northwest, from managed care to large health care ... CEO of HealthPlus of Michigan, a health plan serving ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 ... leadership guidebook called “Medicare Breakeven Challenges? A ... guidebook includes:, ,     Formulas for ... aren’t measuring but should be , ... unproductive “white space” and ensures sustained efficient ...
Breaking Medicine News(10 mins):Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 2Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 3Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 4Health News:Choices Recovery Mishawaka Talks About Overcoming Adversity with Actor Matthew Ziff at the “RockNRolla Movie Awards” EcoLuxe Lounge 2Health News:LIVESTRONG & Bolder Broadcasting Present Special Edition of Conquering Kilimanjaro 2Health News:LIVESTRONG & Bolder Broadcasting Present Special Edition of Conquering Kilimanjaro 3Health News:Buckeye Health Plan Announces New Chief Executive Officer 2Health News:Buckeye Health Plan Announces New Chief Executive Officer 3Health News:Care Logistics Publishes a New Hospital Guidebook for Achieving Medicare Breakeven 2
... , , , INDIANAPOLIS, ... District of Indiana today upheld Eli Lilly and Company,s (NYSE: ... tablets). In the case of Eli Lilly and Company ... favor of Lilly on all accounts for these method-of-use patents, ...
... , , SAN FRANCISCO, ... a leader in the development, manufacturing and sales of products ... disease, said today that the two-year results of the Fractional ... confirm the importance of FFR in improving patient outcomes and ...
... and communication can alleviate the psychological distress and burnout ... University of Rochester Medical Center researchers report in today,s ... Association ( JAMA ). The training also ... and enhance patient-centered care, according to the researchers, who ...
... , , , ... today that the organization,s mail-in pharmacy benefits ranked highest in ... National Pharmacy Study(SM). The study measured more than a ... across five factors: ordering convenience, delivery convenience, medication availability and ...
... building in Congress ... empowering small dollar ... Elections Now Coalition, which represents seven national campaign reform organizations, today praised Rep. Peter DeFazio ... cosponsoring the bipartisan Fair Elections Now Act, H.R. 1826. , , The ...
... , CHICAGO, Sept. 23 , , Study 1 highlights : ... blood pressure in men. , A drug used to treat gout seems to ... Study 2 highlights : , , A study ... blood pressure, weight gain and behavior. , , , ...
Cached Medicine News:Health News:U.S. District Court Upholds Validity of Lilly's Evista Patents Through 2014 2Health News:U.S. District Court Upholds Validity of Lilly's Evista Patents Through 2014 3Health News:Volcano Corporation Praises FAME Study Results 2Health News:Volcano Corporation Praises FAME Study Results 3Health News:Volcano Corporation Praises FAME Study Results 4Health News:Volcano Corporation Praises FAME Study Results 5Health News:Mindful meditation, shared dialogues reduce physician burnout 2Health News:Mindful meditation, shared dialogues reduce physician burnout 3Health News:Mindful meditation, shared dialogues reduce physician burnout 4Health News:Kaiser Permanente Recognized by J.D. Power and Associates as Highest in Customer Satisfaction Among Mail-Order Pharmacies 2Health News:Kaiser Permanente Recognized by J.D. Power and Associates as Highest in Customer Satisfaction Among Mail-Order Pharmacies 3Health News:American Heart Association Meeting Report: High-Sugar Diet Increases Men's Blood Pressure; Gout Drug Protective 2Health News:American Heart Association Meeting Report: High-Sugar Diet Increases Men's Blood Pressure; Gout Drug Protective 3Health News:American Heart Association Meeting Report: High-Sugar Diet Increases Men's Blood Pressure; Gout Drug Protective 4Health News:American Heart Association Meeting Report: High-Sugar Diet Increases Men's Blood Pressure; Gout Drug Protective 5Health News:American Heart Association Meeting Report: High-Sugar Diet Increases Men's Blood Pressure; Gout Drug Protective 6
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
Used for temporary urine collection. The leg bag is designed for use with the Non-Adhesive Silicone Condom Catheter. Supplied non-sterile. Reusable. Intended for single patient use only....
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
... The Self-Cath Closed System is ... a method for safe, simple catheterization ... urinary tract infections. It includes ... The new EasyOff tear tab ...
Medicine Products: